Écrit par GlobalData | 21 Avril 2016

LONDON, UK (GlobalData), 20 April 2016 - The recent FDA approval of Gilead Sciences’ drug Descovy (emtricitabine/tenofovir alafenamide [TAF]) in the treatment of human immunodeficiency virus (HIV) will boost the company’s TAF-based HIV portfolio, and allow Gilead to stay on top of a fast-changing treatment landscape, according to an analyst with research and consulting firm...

Écrit par ANPAA | 21 Avril 2016

Le rapport de la Grande Conférence sur le sport professionnel français remis le 19 avril à Thierry Braillard, Secrétaire d'Etat aux Sports, propose une mesure – la préconisation 3.3 – dangereuse pour la santé et la sécurité publiques. En effet, celle-ci propose de "harmoniser la législation française et européenne sur les règles de publicité pour les marques d’alcool"...

Écrit par WHO | 21 Avril 2016

Copenhagen, 20 April 2016 - The European Region is the first in the world to have achieved interruption of indigenous malaria transmission. The number of indigenous malaria cases dropped from 90 712 in 1995 to zero cases in 2015. Ahead of World Malaria Day 2016, WHO announces that the European Region hit its 2015 target to wipe out malaria, thus contributing to the global goal to "End...

Écrit par OMS | 19 Avril 2016

19 April 2016 – As Angola grapples with its worst yellow fever outbreak in decades, the Ministry of Health, with the support of the World Health Organization (WHO) and partners have extended the vaccination campaign beyond the capital Luanda into Huambo and Benguela – 2 of the other 5 provinces reporting local transmission.

Since the outbreak began in December 2015, 1908 suspected...